Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.

MLA

Forero-Castro, Maribel, et al. “Mutations in TP53 and JAK2 Are Independent Prognostic Biomarkers in B-Cell Precursor Acute Lymphoblastic Leukaemia.” British Journal of Cancer, vol. 117, no. 2, July 2017, pp. 256–65. EBSCOhost, https://doi.org/10.1038/bjc.2017.152.

APA

Forero-Castro, M., Robledo, C., Benito, R., Bodega-Mayor, I., Rapado, I., Hernández-Sánchez, M., Abáigar, M., Maria Hernández-Sánchez, J., Quijada-Álamo, M., María Sánchez-Pina, J., Sala-Valdés, M., Araujo-Silva, F., Kohlmann, A., Luis Fuster, J., Arefi, M., de Las Heras, N., Riesco, S., Rodríguez, J. N., Hermosín, L., … Hernández-Rivas, J.-M. (2017). Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia. British Journal of Cancer, 117(2), 256–265. https://doi.org/10.1038/bjc.2017.152

Chicago

Forero-Castro, Maribel, Cristina Robledo, Rocío Benito, Irene Bodega-Mayor, Inmaculada Rapado, María Hernández-Sánchez, María Abáigar, et al. 2017. “Mutations in TP53 and JAK2 Are Independent Prognostic Biomarkers in B-Cell Precursor Acute Lymphoblastic Leukaemia.” British Journal of Cancer 117 (2): 256–65. doi:10.1038/bjc.2017.152.